![Darlene Haslam](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 35 205 $ al 30/06/2026
Darlene J.
Haslam currently works at Alberta Children's Hospital Foundation, as Chairman and Ensign Energy Services, Inc., as Director from 2022.
Ms. Haslam also formerly worked at Providence Therapeutics, Inc., as Director from 2019 to 2022.
Ms. Haslam received her undergraduate degree from the University of Calgary.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/06/2026 | 15.000 ( 0,01 % ) | 35 205 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ENSIGN ENERGY SERVICES INC. | Director/Miembro de la Junta | 17/03/2022 |
Alberta Children's Hospital Foundation
 Alberta Children's Hospital Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Presidente | - |
| Empresas | Cargo | Fin |
|---|---|---|
Providence Therapeutics, Inc.
 Providence Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative immunotherapeutic for cancer treatment | Director/Miembro de la Junta | 01/01/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Ensign Energy Services, Inc.
 Ensign Energy Services, Inc. Contract DrillingIndustrial Services Provides contract well drilling and well services to the oil and natural gas industry | Industrial Services |
University of Calgary
 University of Calgary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alberta Children's Hospital Foundation
Alberta Children's Hospital Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Providence Therapeutics, Inc.
Providence Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative immunotherapeutic for cancer treatment | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
